CONFIRM trial: what is the real efficacy of second-line immunotherapy in mesothelioma?
Author:
Publisher
Elsevier BV
Subject
Oncology
Reference6 articles.
1. Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial;Fennell;Lancet Oncol,2021
2. Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial;Calabrò;Lancet Oncol,2013
3. A systematic review and meta-analysis of second-line therapies for treatment of mesothelioma;Petrelli;Respir Med,2018
4. A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial;Popat;Ann Oncol,2020
5. RAMES study: is there really a role for VEGF inhibition in mesothelioma?;Porta;Lancet Oncol,2021
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mesothelioma-Associated Fibroblasts Modulate the Response of Mesothelioma Patient-Derived Organoids to Chemotherapy via Interleukin-6;International Journal of Molecular Sciences;2024-05-14
2. Pleural mesothelioma: a snapshot of emerging drug targets and opportunities for non-surgical therapeutic advancement;Expert Opinion on Therapeutic Targets;2023-11-02
3. Intratumor microbiota as a novel potential prognostic indicator in mesothelioma;Frontiers in Immunology;2023-03-14
4. Analysis of new treatments proposed for malignant pleural mesothelioma raises concerns about the conduction of clinical trials in oncology;Journal of Translational Medicine;2022-12-13
5. Novel Insights Into Mesothelioma Therapy: Emerging Avenues and Future Prospects;Frontiers in Oncology;2022-06-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3